Krystal Biotech is a US-based clinical-stage biotech company that specializes in gene therapy for rare diseases. They have several products in different stages of clinical trials including beremagene geperpavec (B-VEC) for epidermolysis bullosa, KB105 for ichthyosis and KB301 for aged or damaged skin. The company was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.